SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
747German Merck, Takeda in cancer drug pact Thu Sep 29, 2005 03:05 AM ET FRANKFURTIcebrg-9/29/2005
746Cuban Monoclonal Antibodies Plant Opens in China Nancy Zamora Beijing, Sep 26 Icebrg-9/27/2005
745MorphoSys Starts New Antibody Program With Centocor Tuesday September 6, 2:00 amIcebrg-9/6/2005
744Biogen Idec and PDL Form Global Alliance to Develop and Commercialize Three PhasIcebrg-8/2/2005
743Cuba and Indonesia Join to Fight Cancer Havana, Aug 1 (AIN) Cuba and Indonesia Icebrg-8/1/2005
742Cool article on Ablynx in SciAm - sciam.comnigel bates-7/29/2005
741<i>venture capital-backed, clinical development-stage protein therapeuticsscaram(o)uche-7/28/2005
740Biolex Therapeutics Acquires LemnaGene S.A. Thursday July 28, 9:00 am ET -- FurtIcebrg-7/28/2005
739>> who will likely benefit from restricted production capacity << Lscaram(o)uche-7/22/2005
738Quoting from the August issue of Scientific American;....."A recent analysiSteve Lokness-7/21/2005
737July 18, 2005 08:10 AM US Eastern Timezone Xencor, Inc. Signs Collaboration wittnsaf-7/20/2005
736DOMANTIS AND PEPTECH ANNOUNCE SECOND DOMAIN ANTIBODY DEAL Oncology Collaborationigel bates-7/20/2005
735Roche buys Glycart - Message 21518346nigel bates-7/19/2005
734>>Abgenix claims....To date, scientists from both Lexicon and Abgenix havenigel bates-6/23/2005
733>>Anyone remember what happened with the LEXG / ABGX collaboration ?>&gIcebrg-6/23/2005
732Another deal for XOMA, this time with Lexicon - Message 21437429 Anyone remembnigel bates-6/23/2005
731Diversa and Merck Expand Collaboration to Develop Novel Therapeutic Antibodies nigel bates-6/20/2005
730Only reason I've ever had any interest in XOMA - fortunately almost always fnigel bates-6/20/2005
729All derives from a small company that was in Santa Monica, started by a bunch ofscaram(o)uche-6/18/2005
728XOMA Enters into License Agreement with Merck & Co., Inc. Friday June 17, 2:nigel bates-6/17/2005
727[Bioren -- improver of antibody binding affinity] >>Published online befotuck-6/7/2005
726Thanks, very much, for that..... very important pointers and new info. for mescaram(o)uche-5/21/2005
725Algae to antibodies Tiny San Diego startup wants to help develop medicines cheaIcebrg-5/21/2005
724Morphotek Announces Multi-Project, Research, Evaluation and Collaboration Agreemnigel bates-5/18/2005
723Antibody Expression in a Fraction of the Time 4/26/05 Scientists from Cell GeneIcebrg-4/27/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News